![](/img/cover-not-exists.png)
PCV51 A COST-EFFECTIVENESS ASSESSMENT OF DALTEPARIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) IN MEXICAN ADULT PATIENTS AFTER TOTAL HIP REPLACEMENT
H Arreola-Ornelas, AA Rosado-Buzzo, MDL García-Mollinedo, J Dorantes-Aguilar, J Mould-Quevedo, G Davila-LoaizaVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73813-4
File:
PDF, 89 KB
english, 2009